REPORT ID 6953

United States Oral Anticoagulants Market Report 2017

Publish Date
1-Nov-17
Pages
102
Format
Electronic (PDF)

In this report, the United States Oral Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Oral Anticoagulants market competition by top manufacturers/players, with Oral Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi
    Bristol-Myers Squibb
    Bayer
    Johnson & Johnson
    Aspen
    Boehringer Ingelheim
    Lilly
    Daiichi Sankyo
    Otsuka
    AstraZeneca

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    PAI
    LMWH
    DTI
    DFXa
    VKA
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    VTE
    ACS/MI
    AF
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Oral Anticoagulants Market Report 2017
1 Oral Anticoagulants Overview
    1.1 Product Overview and Scope of Oral Anticoagulants
    1.2 Classification of Oral Anticoagulants by Product Category
        1.2.1 United States Oral Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Oral Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 PAI
        1.2.4 LMWH
        1.2.5 DTI
        1.2.6 DFXa
        1.2.7 VKA
        1.2.8 Others
    1.3 United States Oral Anticoagulants Market by Application/End Users
        1.3.1 United States Oral Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Others
    1.4 United States Oral Anticoagulants Market by Region
        1.4.1 United States Oral Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Oral Anticoagulants Status and Prospect (2012-2022)
        1.4.3 Southwest Oral Anticoagulants Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Oral Anticoagulants Status and Prospect (2012-2022)
        1.4.5 New England Oral Anticoagulants Status and Prospect (2012-2022)
        1.4.6 The South Oral Anticoagulants Status and Prospect (2012-2022)
        1.4.7 The Midwest Oral Anticoagulants Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Oral Anticoagulants (2012-2022)
        1.5.1 United States Oral Anticoagulants Sales and Growth Rate (2012-2022)
        1.5.2 United States Oral Anticoagulants Revenue and Growth Rate (2012-2022)

2 United States Oral Anticoagulants Market Competition by Players/Suppliers
    2.1 United States Oral Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Oral Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Oral Anticoagulants Average Price by Players/Suppliers (2012-2017)
    2.4 United States Oral Anticoagulants Market Competitive Situation and Trends
        2.4.1 United States Oral Anticoagulants Market Concentration Rate
        2.4.2 United States Oral Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Oral Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Anticoagulants Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Oral Anticoagulants Sales and Market Share by Region (2012-2017)
    3.2 United States Oral Anticoagulants Revenue and Market Share by Region (2012-2017)
    3.3 United States Oral Anticoagulants Price by Region (2012-2017)

4 United States Oral Anticoagulants Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Oral Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Oral Anticoagulants Revenue and Market Share by Type (2012-2017)
    4.3 United States Oral Anticoagulants Price by Type (2012-2017)
    4.4 United States Oral Anticoagulants Sales Growth Rate by Type (2012-2017)

5 United States Oral Anticoagulants Sales (Volume) by Application (2012-2017)
    5.1 United States Oral Anticoagulants Sales and Market Share by Application (2012-2017)
    5.2 United States Oral Anticoagulants Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Oral Anticoagulants Players/Suppliers Profiles and Sales Data
    6.1 Sanofi
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oral Anticoagulants Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb
        6.2.2 Oral Anticoagulants Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer
        6.3.2 Oral Anticoagulants Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Johnson & Johnson
        6.4.2 Oral Anticoagulants Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Aspen
        6.5.2 Oral Anticoagulants Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Aspen Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Boehringer Ingelheim
        6.6.2 Oral Anticoagulants Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Lilly
        6.7.2 Oral Anticoagulants Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Lilly Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Daiichi Sankyo
        6.8.2 Oral Anticoagulants Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Otsuka
        6.9.2 Oral Anticoagulants Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Otsuka Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 AstraZeneca
        6.10.2 Oral Anticoagulants Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 AstraZeneca Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Oral Anticoagulants Manufacturing Cost Analysis
    7.1 Oral Anticoagulants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oral Anticoagulants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oral Anticoagulants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Oral Anticoagulants Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Oral Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Oral Anticoagulants Sales Volume Forecast by Type (2017-2022)
    11.3 United States Oral Anticoagulants Sales Volume Forecast by Application (2017-2022)
    11.4 United States Oral Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer